<DOC>
	<DOCNO>NCT00934024</DOCNO>
	<brief_summary>The purpose study evaluate impact varenicline treatment cue induce crave smoke use brain imaging . The investigator hypothesize participant report reduce urges smoke less activation part brain associate craving .</brief_summary>
	<brief_title>Impact Varenicline Blood-Oxygen-Level Dependent ( BOLD ) Functional Magnetic Resonance Imaging ( fMRI ) Activation Smokers</brief_title>
	<detailed_description>Treatment varenicline reduces overall subjective cigarette crave smoke reward nicotine-dependent smoker . This preliminary study explore impact varenicline treatment smoke cue-induced craving associate regional brain activation use BOLD fMRI . Twenty healthy smoker ( 10 male , 10 female ) undergo two BOLD fMRI scan presentation smoking-related neutral cue baseline five week treatment open-label varenicline . The investigator hypothesize participant report reduce urges smoke Questionnaire Smoking Urges-Brief less activation brain area associate crave fMRI 5 week varenicline smoke cessation counseling compare baseline scan .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . Age 21 60 treatmentseeking right hand smoker . 2 . Meet criterion primary nicotine dependence confirm FTND smoke least 70 % day last 30 day prior assessment . 3 . General good health confirm history &amp; physical . 4 . Able read understand questionnaire inform consent . 5 . Motivated quit , willing set target quit date ( TQD ) abstain smoke TDQ . 6 . Participants must negative urine drug screen ( UDS ) pregnancy test prior imaging session begin varenicline treatment . 7 . Female participant use reliable method birth control throughout study . 8 . Demonstrate subjective response cue laboratory cue reactivity session . 1 . Currently meet DSMIV criterion psychoactive substance dependence disorder except nicotine dependence . 2 . Any psychoactive substance abuse within last 30 day evidence subject report urine drug screen . 3 . Use tobacco product . 4 . Current use nicotine replacement therapy , bupropion , smoke cessation treatment . 5 . Previous fail attempt varenicline . 6 . Meets DSMIV criterion current axis I disorder major depression , panic disorder , obsessive compulsive disorder , posttraumatic stress syndrome , bipolar affective disorder , schizophrenia , psychotic disorder organic mental disorder . 7 . Current suicidal ideation plan homicidal ideation . 8 . Need maintenance acute treatment psychoactive medication include antiseizure medication could potentially interfere fMRI . 9 . Clinically significant medical problem would impair participation limit ability participate scan . 10 . Sexually active female childbearing potential pregnant , nursing , use reliable form birth control . 11 . Has current charge pending violent crime ( include DUI related offense ) . 12 . Persons ferrous metal implant pacemaker since fMRI use .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>nicotine dependence</keyword>
	<keyword>tobacco</keyword>
	<keyword>smoking</keyword>
</DOC>